Mesa Laboratories (MLAB) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart

Mesa Laboratories Revenue Highlights

Latest Revenue (Q)

$58.17M

Main Segment (Y)

Sterilization and Disinfection Control

Main Geography (Y)

UNITED STATES

Mesa Laboratories Revenue by Period

Mesa Laboratories Revenue by Year

Date	Revenue	Change
2024-03-31	-	-100.00%
2023-03-31	$219.08M	18.85%
2022-03-31	$184.34M	37.63%
2021-03-31	$133.94M	13.81%
2020-03-31	$117.69M	14.11%
2019-03-31	$103.14M	7.23%
2018-03-31	$96.18M	2.68%
2017-03-31	$93.67M	10.64%
2016-03-31	$84.66M	18.69%
2015-03-31	$71.33M	35.29%
2014-03-31	$52.72M	13.54%
2013-03-31	$46.44M	17.21%
2012-03-31	$39.62M	20.68%
2011-03-31	$32.83M	49.69%
2010-03-31	$21.93M	1.82%
2009-03-31	$21.54M	10.11%
2008-03-31	$19.56M	13.43%
2007-03-31	$17.24M	48.86%
2006-03-31	$11.58M	15.36%
2005-03-31	$10.04M	10.03%
2004-03-31	$9.13M	0.49%
2003-03-31	$9.08M	0.42%
2002-03-31	$9.04M	-0.62%
2001-03-31	$9.10M	5.14%
2000-03-31	$8.66M	6.86%
1999-03-31	$8.10M	2.53%
1998-03-31	$7.90M	1.28%
1997-03-31	$7.80M	-3.70%
1996-03-31	$8.10M	22.73%
1995-03-31	$6.60M	6.45%
1994-03-31	$6.20M	-

Mesa Laboratories generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Mesa Laboratories Revenue by Quarter

Date	Revenue	Change
2024-06-30	$58.17M	-1.25%
2024-03-31	$58.90M	10.16%
2023-12-31	$53.47M	0.58%
2023-09-30	$53.16M	4.98%
2023-06-30	$50.65M	-8.90%
2023-03-31	$55.59M	2.40%
2022-12-31	$54.29M	-7.60%
2022-09-30	$58.75M	16.44%
2022-06-30	$50.45M	-14.31%
2022-03-31	$58.88M	7.65%
2021-12-31	$54.70M	52.61%
2021-09-30	$35.84M	2.63%
2021-06-30	$34.92M	-8.02%
2021-03-31	$37.96M	11.10%
2020-12-31	$34.17M	7.26%
2020-09-30	$31.86M	6.41%
2020-06-30	$29.94M	-12.47%
2020-03-31	$34.21M	8.07%
2019-12-31	$31.66M	23.96%
2019-09-30	$25.54M	-2.86%
2019-06-30	$26.29M	-0.60%
2019-03-31	$26.45M	-0.88%
2018-12-31	$26.68M	7.31%
2018-09-30	$24.86M	-1.10%
2018-06-30	$25.14M	-6.47%
2018-03-31	$26.88M	13.56%
2017-12-31	$23.67M	3.12%
2017-09-30	$22.95M	1.24%
2017-06-30	$22.67M	-6.69%
2017-03-31	$24.30M	1.91%
2016-12-31	$23.84M	-2.32%
2016-09-30	$24.41M	15.61%
2016-06-30	$21.11M	-14.90%
2016-03-31	$24.81M	24.60%
2015-12-31	$19.91M	-8.56%
2015-09-30	$21.78M	19.93%
2015-06-30	$18.16M	-2.17%
2015-03-31	$18.56M	4.09%
2014-12-31	$17.83M	-3.83%
2014-09-30	$18.54M	13.05%
2014-06-30	$16.40M	4.37%
2014-03-31	$15.71M	19.81%
2013-12-31	$13.12M	3.47%
2013-09-30	$12.68M	13.00%
2013-06-30	$11.22M	-12.41%
2013-03-31	$12.81M	12.74%
2012-12-31	$11.36M	-2.95%
2012-09-30	$11.71M	10.86%
2012-06-30	$10.56M	-13.29%
2012-03-31	$12.18M	31.53%
2011-12-31	$9.26M	-0.34%
2011-09-30	$9.29M	4.53%
2011-06-30	$8.89M	-10.81%
2011-03-31	$9.96M	30.23%
2010-12-31	$7.65M	-1.32%
2010-09-30	$7.75M	4.01%
2010-06-30	$7.46M	19.72%
2010-03-31	$6.23M	17.09%
2009-12-31	$5.32M	-1.65%
2009-09-30	$5.41M	8.64%
2009-06-30	$4.98M	-8.93%
2009-03-31	$5.46M	2.40%
2008-12-31	$5.34M	-6.02%
2008-09-30	$5.68M	12.37%
2008-06-30	$5.05M	-12.71%
2008-03-31	$5.79M	-

Mesa Laboratories generated $58.17M in revenue during Q1 2025, up -1.25% compared to the previous quarter, and up 104.64% compared to the same period a year ago.

Mesa Laboratories Revenue Breakdown

Mesa Laboratories Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Clinical Genomics	$52.59M	-	-	-	-
Calibration Solutions	$47.76M	-	-	-	-
Sterilization and Disinfection Control	$75.12M	-	-	-	-
Biopharmaceutical Development	$40.71M	-	-	-	-
Product	-	$180.52M	$149.42M	$107.03M	$93.40M
Service	-	$38.56M	-	-	-

Mesa Laboratories's latest annual revenue breakdown by segment (product or service), as of Mar 24: Sterilization and Disinfection Control (34.75%), Clinical Genomics (24.33%), Calibration Solutions (22.09%), and Biopharmaceutical Development (18.83%).

Quarterly Revenue by Product

Product/Service	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Dec 19	Sep 19	Jun 19	Dec 18
Product	$57.83M	$54.29M	$58.75M	$50.45M	$23.97M	$54.70M	$35.84M	$34.92M	-	-	-	-	-	-	-	-	-	-	-	-
Calibration Solutions	-	$12.81M	$12.16M	$11.33M	$11.46M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sterilization and Disinfection Control	-	$22.78M	$19.34M	$17.08M	$15.93M	$15.42M	$13.08M	$11.55M	-	-	-	-	-	-	-	-	-	-	-	-
Clinical Genomics	-	$11.12M	$12.55M	$15.55M	$13.37M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biopharmaceutical Development	-	$12.19M	$9.43M	$9.21M	$9.89M	$10.10M	$8.71M	$9.13M	$5.95M	$5.64M	-	-	-	-	-	-	-	-	-	-
Continuous Monitoring	-	-	-	-	-	-	-	-	-	-	-	-	$4.18M	$3.41M	$3.62M	-	-	-	-	-
Instruments	-	-	-	-	-	-	-	-	-	-	-	-	$8.26M	$8.97M	$7.56M	$7.68M	$10.01M	$8.96M	$9.54M	$9.34M
Cold Chain Monitoring	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$3.25M	$4.16M	$3.59M	$3.32M	$3.74M
Sterilzation and Disinfection Control	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$13.07M	$11.62M	$12.09M	$12.11M	$11.54M
Cold Chain Packaging	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$229.00K	$896.00K	$1.32M	$2.05M

Mesa Laboratories's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product (100.00%).

Mesa Laboratories Revenue Breakdown by Country

Annual Revenue by Country

Country	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Other	$84.86M	$76.00M	-	-	-
CHINA	$24.93M	$25.80M	-	-	-
UNITED STATES	$106.39M	$117.28M	$99.07M	$71.39M	$66.34M
Non-US	-	-	$85.27M	$62.55M	$51.34M
Product	-	-	$149.42M	-	-

Mesa Laboratories's latest annual revenue breakdown by geography, as of Mar 24: UNITED STATES (49.21%), Other (39.25%), and CHINA (11.53%).

Quarterly Revenue by Country

Country	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19
Other	$22.36M	$25.36M	$22.94M	$18.56M	$18.00M	$18.16M	$20.28M	-	-	-	-	-	-	-	-	-	-	-	-	-
UNITED STATES	$28.08M	$27.19M	$25.59M	$27.07M	$26.54M	$28.64M	$30.99M	$29.12M	$30.82M	$30.41M	$19.38M	$18.45M	$19.14M	$18.48M	$11.22M	$16.37M	$18.34M	$17.81M	$15.01M	$15.19M
CHINA	$7.39M	$6.35M	$4.94M	$7.53M	$6.11M	$7.48M	$7.48M	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-US	-	-	-	-	-	-	-	$21.33M	$28.06M	$24.28M	$16.46M	$16.46M	$18.82M	$15.69M	$20.64M	$13.57M	$15.87M	$13.85M	$10.53M	$11.10M

Mesa Laboratories's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (48.55%), Other (38.67%), and CHINA (12.78%).

Mesa Laboratories Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
FTV	Fortive	$6.07B	$1.53B
ST	Sensata Technologies	$4.05B	$982.83B
VNT	Vontier	$3.10B	$750.00M
ITRI	Itron	$2.17B	$615.46M
ESE	ESCO	$1.03B	$260.78M
BMI	Badger Meter	$703.59M	$208.44M
COHR	Coherent	$402.00M	$1.31B
VPG	Vishay Precision Group	$355.05M	$75.73M
FCUV	Focus Universal	$1.05M	$19.75K
MLAB	Mesa Laboratories	-	$58.17M

MLAB Revenue FAQ

What is Mesa Laboratories’s yearly revenue?

Mesa Laboratories's yearly revenue for 2024 was $0, representing a decrease of -100.00% compared to 2023. The company's yearly revenue for 2023 was $219.08M, representing an increase of 18.85% compared to 2022. MLAB's yearly revenue for 2022 was $184.34M, representing an increase of 37.63% compared to 2021.

What is Mesa Laboratories’s quarterly revenue?

Mesa Laboratories's quarterly revenue for Q1 2025 was $58.17M, a -1.25% decrease from the previous quarter (Q4 2024), and a 14.86% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $58.9M, a 10.16% increase from the previous quarter (Q3 2024), and a 5.96% increase year-over-year (Q4 2023). MLAB's quarterly revenue for Q3 2024 was $53.47M, a 0.58% increase from the previous quarter (Q2 2024), and a -1.50% decrease year-over-year (Q3 2023).

What is Mesa Laboratories’s revenue growth rate?

Mesa Laboratories's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was -100.00%.

What are Mesa Laboratories’s revenue streams?

Mesa Laboratories's revenue streams in r 24 are Clinical Genomics, Calibration Solutions, Sterilization and Disinfection Control, and Biopharmaceutical Development. Clinical Genomics generated $52.59M in revenue, accounting 24.33% of the company's total revenue Calibration Solutions generated $47.76M in revenue, accounting 22.09% of the company's total revenue Sterilization and Disinfection Control generated $75.12M in revenue, accounting 34.75% of the company's total revenue Biopharmaceutical Development generated $40.71M in revenue, accounting 18.83% of the company's total revenue

What is Mesa Laboratories’s main source of revenue?

For the fiscal year ending Mar 24, the largest source of revenue of Mesa Laboratories was Sterilization and Disinfection Control. This segment made a revenue of $75.12M, representing 34.75% of the company's total revenue.